Cutaneous Oncology Fellowship
Brigham and Women's Hospital
Harvard Medical School
Start Date: July 1, 2023
The Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, is pleased to announce a clinical fellowship in cutaneous oncology for the 2023-2024 academic year. The fellow will develop expertise in the diagnosis and management of a wide range of cutaneous malignancies including melanoma, cutaneous lymphomas, Merkel cell carcinoma, and high-risk basal and squamous cell cancers. The program will include the full spectrum of clinical management, from clinical diagnosis to histopathological confirmation and surgery and chemotherapeutic treatments. A multi-disciplinary approach will be utilized, and the fellow will work closely with dermatologists, dermatopathologists, medical oncologists, and surgical oncologists.
The applicant must be board eligible or board certified in dermatology. Salary will be commensurate with PGY level.
Interested applicants should send a letter describing their background and interest in the program, curriculum vitae and two letters of recommendation to: Nicole LeBoeuf, M.D., Director, Cutaneous Oncology Fellowship Program, Department of Dermatology, Brigham and Women’s Hospital, 221 Longwood Avenue, Boston, MA 02115 or email to firstname.lastname@example.org.
Application deadline: August 13, 2022.
For more information, please visit our website at www.brighamandwomens.org/dermatology .
Brigham Health and the Department of Dermatology are committed to ensuring our diverse community feels welcome, cared for, and valued. Candidates who have experience working with a diverse range of faculty, staff and patients, and who can contribute to the climate of inclusivity are encouraged to identify their experiences in these areas.
"We are an equal opportunity employer, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, gender identity, sexual orientation, pregnancy and pregnancy-related conditions or any other characteristic protected by law.”
Offers of employment and agreement are subject to satisfactory completion of the BWH/BWPO credentialing process and final appointment to the BWH/BWPO Professional Staff by the Trustees of the Hospital, as well as satisfactory completion of all BWH/BWPO pre-employment requirements, including drug screening.